Good morning :)
$
₹
Henry Schein Inc

Henry Schein Inc

HSIC

NASDAQ
Asset Logo

Henry Schein Inc

HSIC

NASDAQ
$86.001.16% (+0.99)
$
₹
$86.001.16% (+0.99)
High
—
—
Low
—
—
Returns
—
—
Loading...
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max

Healthcare

Medical Distribution

Mid Cap

With a market cap of $9.4B the stock is ranked 1009

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

24.68
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

3.08
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$3.43
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

1.74
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

2.96%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

—

Analyst Ratings & Forecast

Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 

Based on 16 analysts reports

Buy
8 analysts
Hold
7 analysts
Sell
1 analyst

Price Upside

+12.64%

Earnings Growth

+8.41%

Rev. Growth

+5.18%

See Detailed Forecast

Company Profile

Company Profile

Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services. It also markets and sells a portfolio of consumable merchandise under its own corporate brand. The Global Specialty Products segment engage in manufacturing, marketing, and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products, and other health care-related products and services. The Global Technology segment is involved in the development and distribution of practice management software, e-services, and other products which are distributed to health care providers. The company serves dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics, home health providers, and other alternate care clinics. It has a strategic partnership with GoTu Technology to help dental practices address ongoing staffing challenges. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services. It also markets and sells a portfolio of consumable merchandise under its own corporate brand. The Global Specialty Products segment engage in manufacturing, marketing, and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products, and other health care-related products and services. The Global Technology segment is involved in the development and distribution of practice management software, e-services, and other products which are distributed to health care providers. The company serves dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics, home health providers, and other alternate care clinics. It has a strategic partnership with GoTu Technology to help dental practices address ongoing staffing challenges. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

Peers

Compare with peers Compare with peers 

Peers

Compare with peers Compare with peers 
McKesson Corporation
MCK
McKesson Corporation
P/E Ratio
27.60
27.60
1Y Return
27.23%
27.23%
Buy Reco %
81.25
81.25
Cencora Inc.
COR
Cencora Inc.
P/E Ratio
25.24
25.24
1Y Return
3.08%
3.08%
Buy Reco %
71.42
71.42
Cardinal Health Inc
CAH
Cardinal Health Inc
P/E Ratio
34.94
34.94
1Y Return
61.39%
61.39%
Buy Reco %
82.35
82.35
Adapthealth Corp
AHCO
Adapthealth Corp
P/E Ratio
—
—
1Y Return
35.38%
35.38%
Buy Reco %
100.00
100.00
EDAP TMS S.A.
FOCL
EDAP TMS S.A.
P/E Ratio
—
—
1Y Return
21.17%
21.17%
Buy Reco %
60.00
60.00
Compare with Peers

Forecast

Forecast

Price

Revenue

Earnings

Price Forecast

Price Forecast

Higher price growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The 12-month consensus target implies 12.64% growth, versus a trailing 3-year CAGR of 8.46%.

2026
Current$86Baseline
Analyst Target - 1 year
Target$96.87+12.64%

All values in $

202220232024202520262027$73.35$84.42$95.49Target+12.64%
2026
Current$86Baseline
Analyst Target - 1 year
Target$96.87+12.64%

All values in $

Revenue Forecast

Revenue Forecast

Higher revenue growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The next fiscal year's mean estimate implies 5.18% growth, versus a trailing 3-year CAGR of 1.40%.

2025
Current$13.18Baseline
Forecast for Dec 2026
High$13.91+5.54%
Average$13.86+5.18%
Low$13.82+4.86%

All values in $ Billion

20212022202320242025202612.4012.6412.3312.6713.18Low+4.86%Average+5.18%High+5.54%
2025
Current$13.18Baseline
Forecast for Dec 2026
High$13.91+5.54%
Average$13.86+5.18%
Low$13.82+4.86%

All values in $ Billion

Earnings Per Share Forecast

Earnings Per Share Forecast

Higher earnings growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The next fiscal year's mean estimate implies 8.41% growth, versus a trailing 3-year CAGR of 0.07%.

2025
Current$4.97Baseline
Forecast for Dec 2026
High$5.66+13.88%
Average$5.39+8.41%
Low$5.33+7.32%

All values in $

2021202220232024202520264.524.964.54.744.97Low+7.32%Average+8.41%High+13.88%
2025
Current$4.97Baseline
Forecast for Dec 2026
High$5.66+13.88%
Average$5.39+8.41%
Low$5.33+7.32%

All values in $

Financials

Financials

Income

Balance Sheet

Cash Flow

3.3
0.1
3.4
0.1
3.3
0.1
3.4
0
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
Financial YearQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Total Revenue3.173.133.173.193.163.243.333.433.363.45
Net Income0.090.100.090.090.110.080.100.100.100.09
Net Profit Margin2.93%3.31%3.11%2.94%3.47%2.65%3.02%2.93%3.17%2.71%
See CostsAll values in $ Billion

Peers

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareMedical Distribution

Valuation

Returns

Forecast

ScreenerCompare valuation on Screener
StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
Henry Schein Inc 24.683.081.74
McKesson Corporation27.605.041.66
Cencora Inc.25.2419.530.65
ScreenerCompare valuation on Screener

Price Comparison

Price Comparison

Compare HSIC with any stock or ETF
Compare HSIC with any stock or ETF
Comparing from
HSIC
MCK
COR
Loading...

Frequently asked questions

  1. Henry Schein Inc (HSIC) share price today is $86.00 as of October 23, 2026 at 1:30 AM IST. The stock touched a day high of $86.22 and a day low of $84.91.

  2. Henry Schein Inc stock trades on NASDAQ under the ticker symbol HSIC.

  3. Henry Schein Inc's market capitalization is $9.43B as of October 23, 2026 at 1:30 AM IST.

  4. Henry Schein Inc's price-to-earnings (P/E) ratio is 24.68 as of October 22, 2026.

  5. Henry Schein Inc's price-to-book (P/B) ratio is 3.08 as of October 22, 2026.

  6. Yes, You can buy Henry Schein Inc shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  7. Indian investors can buy Henry Schein Inc shares in three steps: 1. Search Henry Schein Inc on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  8. Since Henry Schein Inc trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  9. Indian investors can start investing in Henry Schein Inc (HSIC) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.1162 shares at the current price of $86.00.

Loading...